GSK-113171

Study Sponsor: GSK

Study Title

Safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ investigational vaccination regimen in children aged 12-23 months at the time of first vaccination.

Medicine or Vaccine (generic name)

GSK2189242A

Sponsor Identification Number

113171

Trial Registry Identification Number(#'s)

NCT00985751 2009-012701-19

Medical Condition

Infections, Streptococcal

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=113171

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00985751

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2009-012701-19

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided. A reporting and analysis plan is not available for this study.

Date Added to this Site

November 2016